FDA Okays Smith & Nephew’s Birmingham Hip, But Orders Postmarket Studies
This article was originally published in The Gray Sheet
Executive Summary
Smith & Nephew will be the first to offer hip resurfacing in the U.S. after FDA approved the firm's Birmingham system May 9